CDx

FDA Approves Merck's #KEYTRUDA in Metastatic NSCLC for First-Line Treatment for Tumors with High PD-L1 goo.gl/gta14D

Last call for #CDx2016 registration! This Wed-Thurs. in Edison, NJ! Register now! goo.gl/9vvOgT

Join peers from Merck, BMS, Janssen and Medimmune for CDx 2016: goo.gl/9vvOgT

Last call for #CDx2016 registration! Nov 2-3 in Edison, NJ! Register now! goo.gl/9vvOgT

Celgene, Agios to partner with Abbott to identify IDH mutations as CDx for Rx goo.gl/sguq52

Interested in attending CDx Symposium 2016 on Nov 2-3rd? See our attendee list: goo.gl/WuO1VV

Join Matt Marton of Merck, speaker at CDx 2016 Nov 2-3 in Edison! Learn more and register: goo.gl/QMEQMY

TODAY! Free webinar-- DTs in IMMUNO-ONCOLOGY: Translating cancer research into targeted therapeutics goo.gl/oSJF2P

Cancer Genetics, Inc. entered a strategic alliance & partnership with ApoCell goo.gl/6ohFk0

Join us Thurs 10/13 for a webinar-DTs in IMMUNO-ONCOLOGY: Translating cancer research into targeted therapeutics goo.gl/oSJF2P

Thurs @ 11 am! Join us for webinar: DTs in IMMUNO-ONCOLOGY: Translating cancer research into targeted therapeutics goo.gl/oSJF2P

LabCorp announces launch of new CDx for non-small cell lung cancer goo.gl/zj25Bt

Join us for a FREE webinar on 10/13 DTs in IMMUNO-ONCOLOGY: Translating cancer research into targeted therapeutics goo.gl/oSJF2P

Attendee list for CDx 2016 Just Announced: goo.gl/WuO1VV

Don't miss Erwin Sablon of Biocartis at CDx 2016! #companiondx2016 bit.ly/29e1KCy

AbbVie, Myriad Genetics Expand Strategic Research Collaboration #companiondx2016 bit.ly/29YgpOg

Register now for CDx 2016! #companiondx2016 bit.ly/29uZb0M

AbbVie, Myriad Genetics Expand Strategic Research Collaboration #companiondx2016 bit.ly/29YgpOg

Don't miss the Companion Diagnostics Symposium 2016, Nov 2-3, 2016! #companiondx2016 bit.ly/29uZb0M

Archer DX partners with Illumina to oncology assays to global markets #companiondx2016 bit.ly/2afW8q2